Extended Low-Dose Valganciclovir Is Effective Prophylaxis Against Cytomegalovirus in High-Risk Kidney Transplant Recipients With Near-Complete Eradication of Late-Onset Disease

Autor: Fayek, S.A., Beshears, E., Lieber, R., Alvey, N., Sauer, A., Poirier, J., Hollinger, E.F., Olaitan, O.K., Jensik, S., Geyston, J., Brokhof, M.M., Hodowanec, A.C., Hertl, M., Simon, D.M.
Zdroj: In Transplantation Proceedings July-August 2016 48(6):2056-2064
Databáze: ScienceDirect